AI assistant
Sending…
Jasper Therapeutics, Inc. — Director's Dealing 2021
Oct 1, 2021
34406_dirs_2021-10-01_54c2a954-e163-4e66-9866-8bc3441015b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Jasper Therapeutics, Inc. (JSPR)
CIK: 0001788028
Period of Report: 2021-09-24
Reporting Person: Klein Lawrence Otto (Director)
More from Jasper Therapeutics, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Feb 10
Major Shareholding Notification
2026
Jan 26
Regulatory Filings
2026
Jan 8
Board/Management Information
2026
Jan 7
Director's Dealing
2026
Jan 6